© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, CorMedix Inc. (CRMD) shows an Average True Range (ATR) of 0.54 and an Enterprise Value of 249.1M. Its average trading volume over the past 3 months is 2.73M, indicating liquidity. These fundamental metrics provide insight into CRMD's underlying financial health and market activity.
CorMedix Inc. (CRMD) technical indicators as of December 22, 2025: the SMA 20 is 11.72%, SMA 50 at 10.63%, and SMA 200 at 7.22%. The RSI 14 value is 65.38, suggesting its current momentum. These technical analysis signals help assess CRMD's price trends and potential future movements.
CorMedix Inc. (CRMD) stock performance overview as of December 22, 2025: The 52-week high is $17.43 (currently -31.04% below), and the 52-week low is $5.6 (currently 114.64% above). Over the past year, CRMD's performance is 43.44%, compared to the S&P 500's 12.87% change.
According to market data, CorMedix Inc. (CRMD) stock's recent performance metrics show that over the last month, CRMD is 19.36%, with a Year-to-Date (YTD) performance of 48.4%. Over the past year, the stock has seen a 43.44% change. These figures summarize CRMD's price movements across various periods, reflecting its historical returns.
According to current financial data, CRMD stock's P/E (TTM) ratio is 5.62, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CRMD, including P/S (4.42), P/B (2.44), and P/FCF (12.73), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.